Baker Avenue Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-6,453
Closed -$1.08M 259
2019
Q2
$1.08M Sell
6,453
-29,349
-82% -$4.06M 0.09% 133
2019
Q1
$5.24M Buy
35,802
+17,536
+96% +$2.54M 0.43% 61
2018
Q4
$2.44M Buy
18,266
+9,611
+111% +$1.58M 0.24% 83
2018
Q3
$1.65M Sell
8,655
-79
-0.9% -$14.5K 0.14% 113
2018
Q2
$1.46M Buy
8,734
+2,563
+42% +$411K 0.13% 118
2018
Q1
$1.04M Buy
+6,171
New +$1.04M 0.09% 151
2015
Q3
Sell
-14,189
Closed -$4.31M 251
2015
Q2
$4.31M Sell
14,189
-1,682
-11% -$502K 0.57% 48
2015
Q1
$4.72M Buy
15,871
+502
+3% +$143K 0.63% 40
2014
Q4
$3.96M Buy
15,369
+1,245
+9% +$311K 0.55% 50
2014
Q3
$3.41M Buy
14,124
+374
+3% +$83.7K 0.48% 62
2014
Q2
$3.07M Sell
13,750
-10,553
-43% -$2.19M 0.44% 73
2014
Q1
$2.95M Buy
24,303
+1,623
+7% +$321K 0.5% 64
2013
Q4
$3.81M Buy
22,680
+460
+2% +$71.9K 0.73% 34
2013
Q3
$3.2M Buy
+22,220
New +$2.96M 0.67% 42

Other funds holding AGN

Baker Avenue Asset Management's AGN Position: Q3 2019 in Review

Baker Avenue Asset Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 6,453 shares — an estimated $1.08M sold.

Baker Avenue Asset Management first reported a position in AGN in Q3 2013 and held it in 14 quarters. The position peaked at $5.24M in Q1 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Baker Avenue Asset Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Baker Avenue Asset Management sold 6,453 Allergan plc shares in Q3 2019, an estimated $1.08M.
  • Baker Avenue Asset Management first reported a position in Allergan plc in Q3 2013 and held it in 14 quarters.
  • Baker Avenue Asset Management's Allergan plc position peaked at $5.24M in Q1 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Baker Avenue Asset Management's 13F filing for Q3 2019, filed 15 Nov 2019.